Regentis Biomaterials RGNT
NYSE RGNT
$1.31 +0.04 (+3.15%)
As of: Nov 10, 2026 · 3:59 PM EST

Regentis Biomaterials (RGNT) Accounts Payables (2024 - 2026)

Updated

Analysis

Regentis Biomaterials (RGNT) Accounts Payables (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 3.09 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn 4.66 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn 1.74 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn 279.50 Mn
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn 2.70 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn 1.63 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 1.25 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn 199.70 Mn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 6.11 Bn
10 Regentis Biomaterials 753,769.54 753,769.54 - 195,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 195,000.00
Dec 31, 2025 266,000.00
Dec 31, 2024 252,000.00
API Access

Regentis Biomaterials Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=RGNT&period=max&api_key=YOUR_API_KEY